中国组织工程研究与临床康复
中國組織工程研究與臨床康複
중국조직공정연구여림상강복
JOURNAL OF CLINICAL REHABILITATIVE TISSUE ENGINEERING RESEARCH
2008年
40期
7935-7938
,共4页
肾移植%移植物排斥%转化生长因子β%基因型%器官移植
腎移植%移植物排斥%轉化生長因子β%基因型%器官移植
신이식%이식물배척%전화생장인자β%기인형%기관이식
背景:免疫损伤是慢性排斥反应的主要发病机制,与多种免疫相关基因多态性有关,尤其是转化生长因子β1基因多态性更显重要.目前关于转化生长因子β1基因多态性与移植肾慢性排斥反应的关系,不同的学者研究结果各异.目的:分析供、受者转化生长因子β1基因型与移植肾慢性排斥反应的关系.设计:前瞻性病例分析.单位:解放军南京军区福州总医院泌尿外科,全军器官移植中心.对象:选择2000-06/2001-05在解放军南京军区福州总医院首次施行尸肾移植的受者144例和其中114例的供者65例(另30例缺乏供者血液标本).手术方案得到医院伦理道德委员会批准.方法:用序列特异引物聚合酶链反应方法,在肾移植前对肾移植受者(n=144)和其中114例的供者(n=65)进行转化生长因子β1基因型检测.术后对受者进行5年随访,追踪移植肾慢性排斥反应发生情况,分析受者基因型、供者基因型及供、受者基因型组合对移植肾功能的影响.主要观察指标:[1]转化生长因子β1不同基因型的肾移植供、受者慢性排斥反应的发生率.[2]肾移植供、受者转化生长因子β1不同基因型组合慢性排斥反应的发生率.结果:[1]高分泌基因型组受者的慢性排斥反应发生率高于中低分泌基因型组(x2=10.091,P<0.01);两组移植肾慢性排斥反应发生率差异无显著性意义(x2=0.002,P>0.05).[2]供、受者均为高分泌基因型组合的受者移植肾慢性排斥反应发生率高于所有其他基因型组合者(x2=4.352,P<0.05);供、受者均为中低分泌基因型的受者慢性排斥反应发生率低十所有其他基因型组合者(x2=4.134,P<0.05).结论:肾移植术前同时检测移植供、受者转化生长因子β1基因多态性,有助于术前准确预测和评价移植后远期效果,指导术前做出合理的供、受者匹配.
揹景:免疫損傷是慢性排斥反應的主要髮病機製,與多種免疫相關基因多態性有關,尤其是轉化生長因子β1基因多態性更顯重要.目前關于轉化生長因子β1基因多態性與移植腎慢性排斥反應的關繫,不同的學者研究結果各異.目的:分析供、受者轉化生長因子β1基因型與移植腎慢性排斥反應的關繫.設計:前瞻性病例分析.單位:解放軍南京軍區福州總醫院泌尿外科,全軍器官移植中心.對象:選擇2000-06/2001-05在解放軍南京軍區福州總醫院首次施行尸腎移植的受者144例和其中114例的供者65例(另30例缺乏供者血液標本).手術方案得到醫院倫理道德委員會批準.方法:用序列特異引物聚閤酶鏈反應方法,在腎移植前對腎移植受者(n=144)和其中114例的供者(n=65)進行轉化生長因子β1基因型檢測.術後對受者進行5年隨訪,追蹤移植腎慢性排斥反應髮生情況,分析受者基因型、供者基因型及供、受者基因型組閤對移植腎功能的影響.主要觀察指標:[1]轉化生長因子β1不同基因型的腎移植供、受者慢性排斥反應的髮生率.[2]腎移植供、受者轉化生長因子β1不同基因型組閤慢性排斥反應的髮生率.結果:[1]高分泌基因型組受者的慢性排斥反應髮生率高于中低分泌基因型組(x2=10.091,P<0.01);兩組移植腎慢性排斥反應髮生率差異無顯著性意義(x2=0.002,P>0.05).[2]供、受者均為高分泌基因型組閤的受者移植腎慢性排斥反應髮生率高于所有其他基因型組閤者(x2=4.352,P<0.05);供、受者均為中低分泌基因型的受者慢性排斥反應髮生率低十所有其他基因型組閤者(x2=4.134,P<0.05).結論:腎移植術前同時檢測移植供、受者轉化生長因子β1基因多態性,有助于術前準確預測和評價移植後遠期效果,指導術前做齣閤理的供、受者匹配.
배경:면역손상시만성배척반응적주요발병궤제,여다충면역상관기인다태성유관,우기시전화생장인자β1기인다태성경현중요.목전관우전화생장인자β1기인다태성여이식신만성배척반응적관계,불동적학자연구결과각이.목적:분석공、수자전화생장인자β1기인형여이식신만성배척반응적관계.설계:전첨성병례분석.단위:해방군남경군구복주총의원비뇨외과,전군기관이식중심.대상:선택2000-06/2001-05재해방군남경군구복주총의원수차시행시신이식적수자144례화기중114례적공자65례(령30례결핍공자혈액표본).수술방안득도의원윤리도덕위원회비준.방법:용서렬특이인물취합매련반응방법,재신이식전대신이식수자(n=144)화기중114례적공자(n=65)진행전화생장인자β1기인형검측.술후대수자진행5년수방,추종이식신만성배척반응발생정황,분석수자기인형、공자기인형급공、수자기인형조합대이식신공능적영향.주요관찰지표:[1]전화생장인자β1불동기인형적신이식공、수자만성배척반응적발생솔.[2]신이식공、수자전화생장인자β1불동기인형조합만성배척반응적발생솔.결과:[1]고분비기인형조수자적만성배척반응발생솔고우중저분비기인형조(x2=10.091,P<0.01);량조이식신만성배척반응발생솔차이무현저성의의(x2=0.002,P>0.05).[2]공、수자균위고분비기인형조합적수자이식신만성배척반응발생솔고우소유기타기인형조합자(x2=4.352,P<0.05);공、수자균위중저분비기인형적수자만성배척반응발생솔저십소유기타기인형조합자(x2=4.134,P<0.05).결론:신이식술전동시검측이식공、수자전화생장인자β1기인다태성,유조우술전준학예측화평개이식후원기효과,지도술전주출합리적공、수자필배.
BACKGROUND:Immunologic injury is a main pathogenesis of chronic rejection,and it is related to multiple immunological associated-gene polymorphism,in particular,transforming growth factor-β1 gene polymorphism.Recently,there are a lot of researching results of the relationship between TGF-β1 gene polymorphism and chronic rejection.OBJECTIVE:To study the relationship between TGF-β1 genotypes and the chronic renal allograft rejection in recipients and donors.DESIGN:Prospective case analysis.SETTING:Department of Urinary Surgery,Fuzhou General Hospital of Nanjing Military Area Command of Chinese PLA;General Organ Transplantation Center.PARTICWANTS:A total of 144 recipients and 65 out of 114 donors(another 30 cases did not have the blood preparation)were selected from Fuzhou General Hospital of Nanjing Military Area Command of Chinese PLA from Jane 2000 to May 2001.The surgical program was approved by the local ethics committee.METHODS:The TGF-β1 genotypes were detected in 144 recipients before renal transplantation and 65 out of 114 donors by sequence-specific primer polymerase chain reaction.The follow-up lasted for 5 years in recipients after surgery to survey chronic renal allografi rejection;furthermore,the effects of genotypes of recipients,genotypes of donors,and the genotype combination on transplanted renal function were analyzed.MAIN OUTCOME MEASURES:(1)Inciderce of chronic renal allograft reiection in recipients and donors with difierent TGF-β1 genotypes;(2)incidence of chronic renal allograft rejection in recipients and donors with TGF-β1 genotype combination.RESULTS:(1)Incidence of chronic renal allograft rejection in recipients with high-secretory TGF-β1 genotype was significantly higher than that in those with moderate-secretory or low-secretory TGF-β1 genotypes(x2=10.091,P<0.01).There were no significant differences in chronic renal allograft rejection among donors with different TGF-β1 genotypes(x2=0.002,P>0.05).(2)Chronic renal allograft rejection occurred in the recipients with high-secretory TGF-β1 genotype,whose donors also had high-secretory TGF-β1 genotype,and the incidence of chronic renal allograft rejection was significantly higher than that in other recipients with TGF-β1 genotype combination(x2=4.352,P<0.05).While the incidence of chronic renal allograft rejection in the recipients with moderate-secretory and low-secretory TGF-β1 genotypes,whose donors also had moderate-secretory and low-secretory TGF-β1 genotypes was significantly lower than that in other recipients with TGF-β1 genotype combination (x2=4.134,P<0.05).CONCLUSION:The TGF-β1 gene polymorphism is detected in the recipients and donors before renal transplantation to benefit for along-term prognostic factor for chronic renal allograft ejection and an ideal genotype combination between recipients and donors.